Perioperative Efgartigimod for Thymoma and Myasthenia Gravis
Conditions: Myasthenia Gravis Interventions: Drug: Efgartigimod Alfa Sponsors: Shanghai Zhongshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2024 Category: Research Source Type: clinical trials

A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Refractory Generalized Myasthenia Gravis
Conditions: Myasthenia Gravis; Generalized Myasthenia Gravis Interventions: Biological: KYV-101; Drug: Standard lymphodepletion regimen Sponsors: Kyverna Therapeutics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 5, 2024 Category: Research Source Type: clinical trials

Investigation of the Effects of Proprioceptive Neuromuscular Facilitation Exercises in Patients With Myasthenia Gravis
Conditions: Myasthenia Gravis Interventions: Other: proprioceptive neuromuscular facilitation exercise Sponsors: Hacettepe University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials

A Study of Rozanolixizumab in Pediatric Study Participants With Moderate to Severe Generalized Myasthenia Gravis
Conditions: Generalized Myasthenia Gravis Interventions: Drug: rozanolixizumab Sponsors: UCB Biopharma SRL Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials

Phase 1b/2a Double Blind, Placebo Controlled Study to Evaluate CNP-106 in Subjects With Generalized Myasthenia Gravis
Conditions: Myasthenia Gravis; Generalized Myasthenia; AChR Myasthenia Gravis; MuSK MG Interventions: Drug: CNP-106 Sponsors: COUR Pharmaceutical Development Company, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials

Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis
Conditions: Myasthenia Gravis; Generalized Myasthenia; AChR Myasthenia Gravis; MuSK MG Interventions: Drug: CNP-106; Other: Placebo Sponsors: COUR Pharmaceutical Development Company, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2023 Category: Research Source Type: clinical trials

Univent Tube for Thoracoscopic Thymectomy in Myasthenic Patients
Conditions: Myasthenia Gravis Sponsors: Nguyen Dang Thu; Hanoi Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2023 Category: Research Source Type: clinical trials

A Natural History Study in Participants With DOK7 Congenital Myasthenic Syndromes (CMS)
Conditions: Congenital Myasthenic Syndrome Sponsors: argenx Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials

Vitaccess Real MG Registry
Conditions: Myasthenia Gravis Sponsors: Vitaccess Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
Conditions: Generalized Myasthenia Gravis Interventions: Device: Whole-body Electrical Muscle Stimulation Exercise Sponsors: University of Missouri-Columbia Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
Condition:   Generalized Myasthenia Gravis Intervention:   Drug: Zilucoplan Sponsor:   UCB Biopharma SRL Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
Conditions: Generalized Myasthenia Gravis Interventions: Drug: Zilucoplan Sponsors: UCB Biopharma SRL Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 27, 2023 Category: Research Source Type: clinical trials

A Prospective Cohort Study of Myasthenia Gravis in China
Condition:   Myasthenia Gravis Interventions:   Drug: Steroid Drug;   Other: Withdraw all immunosuppresants Sponsor:   Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 23, 2023 Category: Research Source Type: clinical trials